EpiTOP-a proteochemometric tool for MHC class II binding prediction

Bioinformatics

Volumn 26, Issue 16, 2010, Pages 2066-2068

  Dimitrov, Ivan ^a   Garnev, Panayot ^a   Flower, Darren R ^b   Doytchinova, Irini ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b ASTON UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; HLA-DRB1 ANTIGEN; LIGAND; PEPTIDE;

ALLELE; ARTICLE; COMPUTER PROGRAM; GENETICS; IMMUNOLOGY; METABOLISM;

ALLELES; EPITOPES, T-LYMPHOCYTE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DR ANTIGENS; LIGANDS; PEPTIDES; SOFTWARE;

EID: 77955444879     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btq324     Document Type: Article

References (17)

1. Bradley, A.P. (1997) The use of the area under the ROC curve in the evaluation of machine learning algorithms. Pattern Recognition, 30, 1145-1159.
2. Bui, H.H. et al. (2005) Automated generation and evaluation of specific MHC binding predictive tools: ARB matrix applications. Immunogenetics, 57, 304-314.
3. Dimitrov, I. et al. (2010) Peptide binding to the HLA-DRB1 supertype: a proteochemometrics analysis. Eur. J. Med. Chem., 45, 236-243.
4. Dönnes, P. and Elofsson, A. (2002) Prediction of MHC class I binding peptides, using SVMHC. BMC Bioinformatics, 3, 25.
5. Doytchinova, I.A. and Flower, D.R. (2003) Towards the in silico identification of class II restricted T-cell epitopes: a partial least squares iterative selfconsistent algorithm for affinity prediction. Bioinformatics, 19, 2263-2270.
6. Flower, D.R. (2008) Vaccines: data driven prediction of binders, epitopes and immunog enicity. In Flower, D.R. (ed), Bioinformatics for Vaccinology, Wiley-Blackwell, Chichester, UK, pp.167-216.
7. Hellberg, S. et al. (1987) Peptide quantitative structure-activity relationships, a multivariate approach. J. Med. Chem., 30, 1126-1135.
8. Lapinsh, M. et al. (2001) Development of proteo-chemometrics: a novel technology for the analysis of drug-receptor interactions. Biochim. Biophys. Acta, 1525, 180-190.
9. Lin, H.H. et al. (2008) Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research. BMC Bioinformatics, 9, S22.
10. Nielsen, M. et al. (2007) Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method. BMC Bioinformatics, 8, 238.
11. Nielsen, M. et al. (2008) Quantitative predictions of peptide binding to any HLA-DR molecule of known sequence: NetMHCIIpan. PLoS Comput. Biol., 4, e1000107.
12. Nielsen, M. and Lund, O. (2009) NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction. BMC Bioinformatics, 10, 296.
13. Peters, B. et al. (2005) The immune epitope database and analysis resource: from vision to blueprint. PLoS Biol., 3, e91.
14. Reche, P.A. et al. (2004) Enhancement to the RANKPEP resource for the prediction of peptide binding to MHC molecules using profiles. Immunogenetics, 56, 405-419.
15. Singh, H. and Raghava, G.P.S. (2001) ProPred: prediction of HLA-DR binding sites. Bioinformatics, 17, 1236-1237.
16. Sturniolo, T. et al. (1999) Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices. Nat. Biotechnol., 17, 555-561.
17. Toseland, C.P. et al. (2005) AntiJen: a quantitative immunology database integrating functional, thermodynamic, kinetic, biophysical and cellular data. Immunome Res., 1, 4.